Treatment of chronic heart failure

From WikiLectures

Heart failure is a state, when the heart is not able to pump enough blood.

The drugs used for treatment of chronic heart failure are devided into two groups:

Drugs reducing strain on myocardium

  • ACE inhibitors,
  • AT1 - receptor blockers,
  • Other vasodilators,
  • Beta-blockers,
  • Diuretics.

Drugs with positive inotropic effects

  • Heart glycosides,
  • Other drugs with positive inotropic effects.


Drugs reducing strain on myocardium[edit | edit source]

ACE inhibitors[edit | edit source]

  • Angiotensin converting enzyme inhibitors. The work by decreasing the concentration of circulating angiotensin II, leading to reduced degradation of bradykinin, which stimulates vasodilatory NO synthase.
  • Simultaneous suppresses the sympathetic nervous system - they are also used in the treatment of arterial hypertension.
  • There is an increase in cardiac output, which improves organ perfusion.

Contraindications[edit | edit source]

Pregnancy, hyperkalaemia, bilateral renal artery stenosis, angioneurotic edema.

Side effects[edit | edit source]

Irritant cough, skin rash, angioneurotic edema.

Examples[edit | edit source]

Enalapril, kaptopril, perindopril, ramipril.


AT1 receptor blockers[edit | edit source]

  • They antagonize the action of angiotensin on AT1 receptors (the difference from ACE inhibitors is, that they do not lead to a delayed degradation of bradykinin, which is responsible for ACE inhibitors side effects).
  • They are recommended for intolerance to ACE inhibitors.

Contraindications[edit | edit source]

Pregnancy, hyperkalaemia, bilateral renal artery stenosis.

Examples[edit | edit source]

Losartan, valsartan, telmisartan, candesartan.


Other vasodilatators[edit | edit source]

  • A wide group of substances whose mechanism and site of action differ.
  • We divide them into arterial, venous and combined vasodilators (arteries and veins).

Examples[edit | edit source]

Dihydralazin, nitroprusid.


Beta-blockers[edit | edit source]

  • They suppress the sympathoadrenal system, reduce the heart rate and prolong diastole.
  • They are used in stabilized patients.

Contraindications[edit | edit source]

More pronounced bradycardia, AV conduction disorders, hypotension, bronchial asthma.

Examples[edit | edit source]

Metoprolol, succinate, karvedilol, bisoprolol, nebivolol.


Diuretics[edit | edit source]

  • Used only with congestion in small or large circulation.
  • Indicated especially in mild and moderate heart failure - swelling occurs.

Contraindications[edit | edit source]

Patients without swelling, circulatory overload and dyspnoea.

Side effects[edit | edit source]

Hypokalaemia (loop and thiazide diuretics only).

Examples[edit | edit source]

  • loop - furosemid,
  • thiazide - hydrochlorthiazid,
  • aldosterone receptor inhibitors - spironolakton.


Drugs with positive inotropic effects[edit | edit source]

Cardiac glycosides[edit | edit source]

  • These are cardiotonics, which are substances that increase myocardial contractility.
  • They induce ionic changes caused by inhibition of Na + / K + -ATPase in cardiomyocytes.
  • They alleviate symptoms, but do not improve the prognosis of the disease.

Side effects[edit | edit source]

They are relatively common - anorexia, nausea, bradycardia, etc.

Examples[edit | edit source]

Digoxin.


Other drugs with positive inotropic effects.[edit | edit source]

  • These are drugs given for short periods in acute conditions (long-term use has a negative effect).
  • Indications are acute heart failure or exacerbation of chronic failure.


Sympathomimetics[edit | edit source]

Examples[edit | edit source]

Dopamin, dobutamin.


Inhibitors of phosphodiesterase III[edit | edit source]

  • I.v. application especially in acute heart failure.
Examples[edit | edit source]

Amrinon, milrinon.


Calcium sensitizers[edit | edit source]

  • They increase the sensitivity of troponin C to calcium.
  • They are used as adjunctive therapy in acutely decompensated chronic heart failure.
Examples[edit | edit source]

Levosimendan.

References[edit | edit source]

References[edit | edit source]

1. LINCOVÁ, Dagmar and Hassan FARGHALI, et al. Basic and applied pharmacology. 2nd edition. Prague: Galén, 2007. 672 pp.  ISBN 978-80-7262-373-0 .

2. PERLIK, Frantisek. Basics of pharmacology. 2nd edition. Prague: Galén, 2011.  ISBN 978-80-7262-759-2 .

Kategorie:farmakologie Kategorie:vnitřní lékařství Kategorie:kardiologie